University of California San Francisco
Give to UCSF
Differentiated thyroid cancer is the most frequently diagnosed thyroid cancer in the U.S. Recently, the American Thyroid Association (ATA) released new practice guidelines for Differentiated thyroid
The KRAS gene mutation, responsible for a quarter of all cancerous tumors, has met its match. Thanks to UCSF research, a tiny “pocket” on a protein that signals the cells to grow and divide was discovered, leading to the world's first FDA-approved drugs that can now target and destroy these cancer cells.
Senescent fibroblasts are aging cells in connective tissue that no longer divide and protect against tumor development. Yet, these same cells can promote cancer growth in a laboratory setting.Until
Lee May, diagnosed with aggressive multiple myeloma at 59, defied odds with cutting-edge treatments at UCSF Health, including CAR-T therapy and NIH-funded innovations. Now 74 and in remission, May credits advanced research for his survival. UCSF leads the way in transforming blood cancer care.
Neurologist Dr. Ptacek explains how "falling back" disrupts the 24-hour circadian clock, affecting mood and performance, with mitigation tips.
UCSF radiation oncologist David Raleigh, MD, PhD, studies the link between brain tumors and injectable birth control.
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to
Ahead of the 2025 Nobel Prize announcements, we take a look back at UCSF's Nobel laureates, their discoveries, and the UCSF research building on their work today.
Thanks to funding from the National Institutes of Health (NIH), UC San Francisco researchers are revolutionizing what we thought we knew about how cancer spreads, opening new paths to cures.
A study led by UCSF and UC Davis concluded that radiation from medical imaging is associated with a higher risk of blood cancers in children.
A new study from UCSF is the first to show a statistically significant increased risk of death in children with acute lymphoblastic leukemia exposed to any pesticide during or after pregnancy.
The UCSF Helen Diller Family Comprehensive Cancer Center announced today the awarding of a Specialized Programs of Research Excellence (SPORE) grant by the National Cancer Institute (NCI) for a
Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the U.S. Despite recent advances, the five-year survival rate for metastatic UC
UCSF researchers studied personalized chemotherapy conditioning for children to maximize chemotherapy exposure for each child versus the current generalized dosage based on weight and age. Their approach reveals higher survival and lower recurrence rates.
A new grant paves the way for UCSF to train one of Mexico’s first molecular pediatric pathologists, providing access to better cancer detection and treatment for the thousands of children diagnosed with cancer in Mexico every year.
A UCSF team discover how breast cancer tumors tunnel into neighboring fat cells to trigger fat breakdown in order to feed on fat and grow.
Scientists found a way to identify and possibly treat a mysterious type of bladder cancer that affects up to 1 in 4 cases.
Medical imaging scans that create detailed images of the body’s internal structures are widely used in medicine. Doctors need them to detect and manage certain types of cancer, assess the extent
In pancreatic cancer, metastasis is often the first sign that a patient even has cancer, and by then, the cancer has spread out of control. Researchers discovered how pancreatic cancer cells migrate to other organs, where they become dangerous enough to kill.
Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting,
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat
A study established new neighborhood characteristics that lead to higher death rates in children with leukemia that can serve as intervention opportunities.
Scientists discover how to rouse the immune system around "cold" tumors, making them vulnerable to cancer-killing immune therapies with checkpoint inhibitors.
CT scans may account for 5% of all cancers annually, according to a new study that cautions against overusing and overdosing CTs.
A cancer drug developed ten years ago at UCSF can also put the brakes on one of prostate cancer's deadliest molecular tricks.
